Automate Your Wheel Strategy on DRIO
With Tiblio's Option Bot, you can configure your own wheel strategy including DRIO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol DRIO
- Rev/Share 0.4173
- Book/Share -0.6237
- PB 0.6381
- Debt/Equity 0.4116
- CurrentRatio 0.0
- ROIC 16.7353
- MktCap 31114580.0
- FreeCF/Share -0.4798
- PFCF -0.9652
- PE -4.1748
- Debt/Assets 0.0
- DivYield 0
- ROE -0.1655
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | DRIO | TD Cowen | Buy | Hold | $2 | $1 | Jan. 29, 2025 |
News
DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Neutral
DarioHealth Corp. (NASDAQ:DRIO ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Lara Dodo - Acting Chief Operating Officer Conference Call Participants Charles Yi - TD Securities David Grossman - Stifel Nicolaus Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth First Quarter 2025 Results Conference Call. At this time, all lines are in a listen-only mode.
Read More
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
Published: May 08, 2025 by: PRNewsWire
Sentiment: Neutral
New data, published in JMIR, demonstrates the value of personalized messaging encouraging flu vaccinations in Dario members with diabetes NEW YORK , May 8, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research published in the Journal of Medical Internet Research ("JMIR") demonstrating the effectiveness of personalized digital health interventions to drive flu vaccine awareness in Dario members living with diabetes. People living with diabetes are at risk of severe complications from the flu, yet low awareness keeps many from receiving an influenza vaccination.
Read More
DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK , May 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 1st quarter ended March 31 st, 2025 and will host a conference call and webcast at 8:30 a.m.
Read More
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives
Published: May 01, 2025 by: PRNewsWire
Sentiment: Neutral
$32.5 million funded at close; up to $17.5 million of additional capital available at the Company's option, subject to the achievement of certain revenue thresholds. Capital from the transaction is expected to support execution of strategic plan and fuel continued growth.
Read More
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Positive
DarioHealth (DRIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript
Published: March 10, 2025 by: Seeking Alpha
Sentiment: Neutral
DarioHealth Corp. (NASDAQ:DRIO ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Conference Call Participants Charles Rhyee - TD Cowen Ashok Kumar - ThinkEquity David Grossman - Stifel Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Fourth Quarter 2024 Results Conference Call. At this time, all lines are in listen-only mode.
Read More
Market News Alert: DarioHealth Beats Q4 Expectations, Reports 398% Growth in B2B Recurring Revenue
Published: March 10, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $DRIO #Biotech--Market News Alerts Updates: Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO) reported fourth quarter revenue of $7.6 million, beating analyst consensus of $7.39 million. B2B2C recurring revenue surged 398% year-over-year to $5.6 million in Q4, driven by rapid employer and health plan adoption of the company's comprehensive chronic care platform. Gross margins in the B2B2C business exceeded 80% over the past three quarters. Full-year 2024 revenue reached $2.
Read More
About DarioHealth Corp. (DRIO)
- IPO Date 2016-03-14
- Website https://www.mydario.com
- Industry Medical - Diagnostics & Research
- CEO Mr. Erez Raphael
- Employees 196